Affiliation:
1. From the Department of Cell Biology and Molecular Medicine, Department of Medicine, Cardiovascular Research Institute, UMDNJ, New Jersey Medical School, Newark.
Abstract
Glycogen synthase kinase-3β (GSK-3β) is a ubiquitously expressed constitutively active serine/threonine kinase that phosphorylates cellular substrates and thereby regulates a wide variety of cellular functions, including development, metabolism, gene transcription, protein translation, cytoskeletal organization, cell cycle regulation, and apoptosis. The activity of GSK-3β is negatively regulated by protein kinase B/Akt and by the Wnt signaling pathway. Increasing lines of evidence show that GSK-3β is an essential negative regulator of cardiac hypertrophy and that the inhibition of GSK-3β by hypertrophic stimuli is an important mechanism contributing to the development of cardiac hypertrophy. GSK-3β also plays an important role in regulating cardiac development. In this review, the role of GSK-3β in cardiac hypertrophy and development and the potential underlying mechanisms are discussed.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Cited by
339 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献